13D Filing: JFL Capital Management and Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

Page 11 of 12

Page 11 of 12 – SEC Filing

SIGNATURES

After reasonable inquiry
and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true,
complete and correct.

Dated: November 2, 2018

JFL PARTNERS FUND LP
By: JFL Capital Management LP
General Partner
By: JFL Capital Holdings LLC
General Partner
By: /s/ Joseph F. Lawler
Name: Joseph F. Lawler
Title: Managing Member
JFL CAPITAL MANAGEMENT LP
By: JFL Capital Holdings LLC
General Partner
By: /s/ Joseph F. Lawler
Name: Joseph F. Lawler
Title: Managing Member
JFL CAPITAL HOLDINGS LLC
By: /s/ Joseph F. Lawler
Name: Joseph F. Lawler
Title: Managing Member
JFL CAPITAL MANAGEMENT LLC
By: /s/ Joseph F. Lawler
Name: Joseph F. Lawler
Title: Managing Member
/s/ Joseph F. Lawler
JOSEPH F. LAWLER
11

Follow Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

Page 11 of 12